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ABSTRACT
The aim of this study was to evaluate the consequences of
interleukin (IL)-4-induced 15-lipoxygenase (15-LO) expression
on leukotriene B4 (LTB4) synthesis in human monocytes. Hu-
man monocytes incubated for 24, 48, and 72 h with IL-4 (10
ng/ml) were stimulated with Ca2-ionophore A23187 (calcimy-
cin; 5 M) or opsonized zymosan. 15(S)-hydroxyeicosatetra-
enoic acid [15(S)-HETE], LTB4, and arachidonic acid (AA) re-
lease were measured by high-performance liquid chromo-
tography/radioimmunoassay, liquid chromotography/tandem
mass spectrometry (LC/MS/MS), or gas chromatography/mass
spectrometry. 15-LO activity was evaluated in AA-treated
monocytes. 15-LO, 5-lipoxygenase (5-LO) and 5-LO activating
protein (FLAP) expression were analyzed by reverse transcrip-
tion-polymerase chain reaction. Neutrophil chemotactic activity
was evaluated using a microtaxis chamber assay. A23187-
induced synthesis of 15(S)-HETE was significantly increased
after treatment with IL-4 (10 ng/ml) for 48 and 72 h (p  0.001).
Concomitant decrease of LTB4 release was observed after 72 h
of incubation with IL-4 (p  0.001). LC/MS/MS analysis con-
firmed the production of 15(S)-HETE and the significant inhibi-
tion of LTB4 synthesis in IL-4-treated monocyte after challenge
with opsonized zymosan. IL-4 treatment induced 15-LO enzy-
matic activity as well as 15-LO mRNA, but did not affect either
5-LO or FLAP mRNA expression in monocytes. Supernatant
from IL-4-treated monocytes showed significantly lower neu-
trophil chemotactic activity than controls. 15(S)-HETE signifi-
cantly inhibited LTB4 production induced by A23187-stimu-
lated human monocytes without affecting AA release. IL-4-
induced expression of 15-LO in monocytes caused a significant
reduction of LTB4 production. Whereas this effect did not re-
flect changes in 5-LO and FLAP mRNA expression, synthetic
15(S)-HETE was able to significantly inhibit the synthesis of
LTB4, without affecting AA release.
Human mononuclear phagocytes migrate from bone mar-
row to inflamed tissue via the peripheral blood system, and
they differentiate into mature macrophages, these being the
phagocytic cell of the lineage. Activated monocytes can pro-
mote the bronchial inflammatory response by releasing nu-
merous mediators, including arachidonic acid metabolites
(Ferreri et al., 1986; Demoly et al., 1994) that contribute to
the development of inflammatory processes such as asthma
(Rankin, 1989). Histological studies on asthmatic subjects
have shown that in airways, macrophages are in close contact
with inflammatory cells, particularly mast cells, basophils,
and Th2 cells (Bradley et al., 1991); these cells are able to
release several immunomodulatory cytokines that may affect
macrophage functions and activities.
Among the cytokines potentially playing a role in the in-
flammatory response IL-4 is known to regulate the expres-
sion of 15-lipoxygenase as well as 15(S)-HETE production in
human monocytes (Conrad et al., 1992). Bronchial allergen
challenge in atopic asthmatic subjects has been found to yield
a 30-fold increase in the concentrations of 15(S)-HETE recov-
ered in bronchoalveolar lavage fluid (Murray et al., 1986);
interestingly, 15(S)-HETE exerts several immunoregulatory
functions that may be relevant in asthma and chronic bron-
chitis (Samuelsson et al., 1987).
Thus, 15(S)-HETE is a potent mucosecretagogue in the
human airway (Marom et al., 1982) and has been reported to
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possess chemotactic activity for neutrophils, contributing to
the recruitment of these cells in the airways (Johnson et al.,
1985; Kirsch et al., 1988). Furthermore, it can prolong the
duration of airway obstruction during the early response to
allergen challenge, augmenting the release of mediators from
mast cells and their effects on airway smooth muscle (Lai et
al., 1990). Bronchial epithelial cells from asthmatic subjects
express more 15-LO immunoreactivity than cells obtained
from normal subjects, and this enhanced expression appears
to correlate with the clinical severity of the disease (Bradding
et al., 1995).
Aside from its proinflammatory actions, 15(S)-HETE may
also modulate the inflammatory response through the inhi-
bition of leukotriene production in a variety of cell types
(Vanderhoek et al., 1982; Profita et al., 2000a). Different
studies have shown that steroid-dependent asthmatic pa-
tients generate 5(S),15(S)-diHETE and lipoxins from 15(S)-
HETE, with a concomitant reduction of LTB4 production
(Chavis et al., 1998); recently it has been shown that FLAP,
in addition to its role in leukotriene biosynthesis, may also
function as a more general lipid-binding protein that signif-
icantly increases the metabolism of 15(S)-HETE by 5-lipoxy-
genase (Mancini et al., 1998).
The ability of IL-4 to induce the expression of 15-LO, and
the potential effect of 15(S)-HETE on leukotriene biosynthe-
sis prompted us to study the effect of IL-4 treatment of
human monocytes on their ability to synthesize leukotrienes.
In this study we provide evidence for a potential anti-inflam-
matory role of IL-4 in human monocytes through the en-
hanced expression of 15-LO and production of 15(S)-HETE,
resulting in inhibition of the synthesis of the potent chemo-
tactic factor LTB4.
Materials and Methods
Reagents. Human recombinant interleukin-4 (IL-4) and poly-
clonal sheep anti-human IL-4 were obtained from Genzyme (Cam-
bridge, MA). All solvents were HPLC grade and were obtained from
Merck (Darmstadt, Germany). Cell culture media were from Invitro-
gen (Carlsbad, CA). Nutritive medium came from Whittaker (Vevi-
ers, Belgium) and fetal calf serum from Hyclone Laboratories (Lo-
gan, UT). 15(S)-HETE RIA kit was purchased from Advanced
Magnetics (Cambridge, MA). LTB4 RIA kit was purchased from
Amersham-Pharmacia Biotec (Milan, Italy). Eicosanoid standards
were from Cayman Chemical (Ann Arbor, MI). Reagents for PCR
were from Promega (Madison, WI). Compound MK-886 was kindly
provided by Dr. A.W. Ford-Hutchinson (Merck Frosst, Pointe Claire,
PQ, Canada).
Purification and Culture of Monocytes. Mononuclear cells
were isolated from buffy coats by density gradient centrifugation
using Ficoll-Hypaque cushions (Conrad et al., 1992). The mononu-
clear cell band was removed and washed three times by centrifuga-
tion with PBS containing CaCl2 and MgCl2 at final concentrations of
0.5 and 1 mM, respectively (PBS buffer). After resuspension (4–20 
106 cells/ml) in RPMI 1640  10% heat-inactivated (56°C, 30 min)
fetal calf serum  1% penicillin-streptomycin solution  1 mM
l-glutamine (RPMI buffer), cells were allowed to adhere to 150-mm
polystyrene tissue culture dishes for 2 h at 37°C. More than 96% of
the adherent cells stained positive for nonspecific esterase, and the
viability was 95%, as assessed by trypan blue exclusion.
After removal of nonadherent cells, the adherent monocytes were
harvested by gentle scraping, washed, and resuspended at the con-
centration of 2  106 cells/ml in RPMI buffer. Monocytes were then
incubated in 6-well plates for 24, 48, and 72 h with IL-4 at the
concentration of 10 ng/ml, which in previous concentration-response
experiments was found to be optimal for 15-LO expression. IL-4-
treated monocytes cells were also incubated in the presence of a
polyclonal sheep anti-human IL-4 antibody (5–40 g/ml). At the end
of the incubation time cells were recovered by gentle scraping,
washed twice, and resuspended at the final concentration of 2  106
cells/ml in PBS buffer for stimulation of eicosanoid synthesis.
LTB4 and 15(S)-HETE Production in Monocytes. IL-4-
treated and untreated cells (2  106 cells/ml) were allowed to adhere
to tissue culture plates for 2 h at 37°C, and were then incubated with
A23187 to a final concentration of 5  106 M for 15 min. Alterna-
tively monocytes were challenged with opsonized zymosan (100 par-
ticles per cell, 1 h at 37°C). Zymosan was opsonized by incubation
with fresh human serum; after boiling 100 mg in 2 ml of PBS for 1 h,
and washing twice with PBS, zymosan was resuspended in PBS (2
ml) and incubated with 6 ml of fresh human serum at 37°C for 20
min. After centrifugation and washing twice with PBS, opsonized
zymosan was resuspended at a concentration of 10 mg/ml. Zymosan
particle count was performed using an hemocytometer.
In separate experiments monocytes were incubated with different
concentrations (105, 106, 107 M) of 15(S)-HETE for 15 min at
37°C prior to A23187 challenge. At the end of the incubation, the cell
supernatants were harvested and, after the addition of the appro-
priate internal standard (prostaglandin B2 for RIA/RP-HPLC, d4-
LTB4 for LC/MS/MS, and d8-AA for gas chromatography/mass spec-
trometry analysis) were stored under an argon atmosphere at
80°C. Radioimmunoassay (RIA) of 15(S)-HETE and LTB4 was per-
formed after RP-HPLC purification, using a gradient liquid chro-
matograph (System Gold apparatus, model 126; Beckman Coulter,
Inc., Fullerton, CA), connected to a diode-array UV detector (model
168; Beckman Coulter, Inc.). The column was developed at a flow
rate of 1 ml/min using a gradient from A (water/acetic acid, 100:0.1,
v/v) to B (acetonitrile/acetic acid, 100:0.1, v/v). Solvent B was set to
20% for 2 min and increased to 100% over 18 min. Retention times of
15(S)-HETE and LTB4 were checked daily using synthetic standards
and were 21.7  0.5 min and 17.2  0.7 min, respectively. The
fractions corresponding to 15(S)-HETE and LTB4 were collected and
evaporated to dryness under a stream of nitrogen, redissolved in RIA
buffer and quantified using a specific RIA, which was performed
according to the manufacturer protocol. Results were expressed as
ng/2  106 cells.
To test if reduction of LTB4 production may result from a shunt of
AA released upon activation from 5-LO to the newly synthesized
15-LO, we performed experiments in which monocytes, after 72 h of
incubation with or without IL-4, were challenged with A23187 in the
presence of 30 M AA. Arachidonic acid release by A23187-stimu-
lated monocytes in the presence of exogenous 15(S)-HETE was eval-
uated by gas chromatography/mass spectrometry upon extraction
and derivatization to the pentafluorobenzyl ester, using d8-AA as an
internal standard as previously published (Hadley et al., 1988).
Analysis of AA Metabolites by Electrospray Ionization-Tan-
dem Mass Spectrometry. Arachidonic acid metabolites generated
by monocytes stimulated with opsonized zymosan, and from selected
experiments carried out with A23187 and exogenous 15(S)-HETE,
were extracted on LC18 solid phase cartridges after addition of
d4-LTB4 as an internal standard, and analyzed by electrospray ion-
ization-tandem mass spectrometry. Aliquots of extracted samples
(50 l) were injected into a RP-HPLC column (Columbus 3 m, 1 
125 mm, Phenomenex, Torrance, CA) directly interfaced into the
electrospray source of a triple quadrupole mass spectrometer (Sciex
API-3000; Perkin Elmer Instruments, Norwalk, CT). The column
was eluted at a flow rate of 50 l min1 using a linear gradient from
15 to 100% solvent B (A: water, 0.05% acetic acid, pH 5.7 with NH3;
B: AcCN/MeOH, 65:35) over 30 min, and arachidonic acid metabo-
lites were detected by selected reaction monitoring, using collision-
induced dissociation and specific transitions for the different metab-
olites (m/z 339 to 198 for d4-LTB4, 335 to 195 for LTB4, 319 to 219 for
15(S)-HETE, and 335 to 201 for 5(S),15(S)-diHETE).
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15-LO Activity and reverse transcription (RT)-polymerase
chain reaction (PCR).To assess 15-LO activity in IL-4-treated and
untreated samples, cells (2  106 cells/ml) were allowed to adhere to
tissue culture plates for 2 h at 37°C, and were then incubated with
100 M AA dissolved in ethanol (0.5% final concentration) for 20 min
in PBS buffer. At the end of the incubation with AA, the cell super-
natants were harvested and, after the addition of prostaglandin B2
as an internal standard, were stored under an argon atmosphere at
80°C, and 15(S)-HETE analyzed as described above.
RT-PCR was performed on total cellular RNA, extracted from
human monocytes (106 cells), according to the method of Chomczyn-
ski and Sacchi (1987), using RNAzol (Biotech Italia, Rome, Italy)
according to the manufacturer’s instructions. Briefly, RNAzol re-
agent was added to the cell pellet, and the cells were suspended.
Chloroform was added to the homogenate and mixed thoroughly.
After 5 min on ice, the suspension was centrifuged at 12,000g for 15
min at 4°C. The colorless upper aqueous phase was transferred to a
fresh tube, an equal volume of isopropanol was added, mixed well,
allowed to stand for 15 min at 4°C, and centrifuged at 12,000g for 15
min at 4°C. The RNA pellet was washed once with 75% ethanol,
air-dried and dissolved in diethylpyrocarbonate (DEPC)-treated wa-
ter (Sigma Chemical Co., St. Louis, MO). The extracted total RNA
was quantified by measurement of absorbance at 260 nm with a
spectrophotometer (DU-65; Beckman Coulter, Inc.). The integrity of
the purified total RNA was determined by visualization of the 28S
and 18S ribosomal RNA bands after electrophoresis of RNA aliquots
on formaldehyde-agarose gel.
Two micrograms of total RNA were reverse transcribed to synthe-
size the first-strand cDNA, and a reverse transcription was carried
out at 37°C for 1 h, in a reaction mixture (total volume, 25 l)
containing 250 ng of oligo(dT)12-18 primer, 10 mM dithiothreitol, 20
U of RNasin ribonuclease inhibitor, 0.5 mM each of dNTP, and 200
U of Moloney murine leukemia virus reverse transcriptase in sup-
plied buffer (all from Invitrogen). The reaction mixture was heated to
98°C for 5 min to inactivate RT, and then cooled to 4°C. Aliquots of
10% from RT reaction were used as templates for PCR amplification.
The sequences of oligonucleotide primers used in PCR (Kaminski
et al., 1996) are as follows: -actin: sense 5-ATTGGCAATGAGCG-
GTTCCG-3, antisense 5-CCGCCGATCCACACGGAGTA-3; 15-LO:
sense 5- CAACGTCATTCTCTGTAGCC-3, antisense 5-CCATGT-
CAGAGACCAGCCCA-3; 5-LO: sense external 5-TTTGAGCTGCT-
GGATGGCAT-3, antisense external 5-GCACCCAGATTTTGGC-
CAAA-3; 5-LO: sense internal 5-GATGCCAACAAAACAGACCC-3,
antisense internal 5-GCCAGTCGTATTTTGCATCC-3; FLAP:
sense external 5-CACTTGCCTTTGAGCGGGTC-3, antisense ex-
ternal 5-AGGAAATGAGAAGTAGAGGG-3; FLAP: sense internal
5-ACACTGCCAACCAGAACTGT-3, antisense internal 5-AGATG-
GTGGTGGAGATCGTC-3. The predicted sizes of amplification prod-
ucts were 281 bp in -actin, 377 bp in 15-LO, 166 bp in 5-LO, and 298
bp in FLAP.
PCR amplification was carried out in a Perkin-Elmer model 2400
thermal cycler, in a 50-l total volume, containing 10 mM Tris-HCl
(pH 9), 50 mM KCl, 0.1% Triton X-100, 2 mM MgCl2, 1 U of Taq DNA
polymerase, 0.2 mM each of dNTPs (Invitrogen), and 0.2 mol/l each
of oligonucleotide primers. -actin was used as a positive control for
the PCR reaction and a no template cDNA control was used as the
negative control. PCR was performed for 30 cycles of denaturation at
94°C for 30 s, annealing at 55°C for 35 s, and extending at 72°C for
45 s, followed by a last extension step at 72°C for 5 min to extend the
partially amplified products. -actin and 15-LO cDNAs were ampli-
fied using standard PCR (30 cycles). 5-LO and FLAP cDNAs were
amplified using the nested PCR technique: after external amplifica-
tion (30 cycles) a 10% aliquot was further amplified with internal
primers for another 30 cycles. PCR products were analyzed by elec-
trophoresis on ethidium bromide-stained 1.8% agarose gels. The gels
were visualized under UV light exposure.
Purification of Neutrophils from Peripheral Blood and
Neutrophil Chemotaxis Assay. Peripheral blood was obtained
from normal subjects and neutrophils were prepared by dextran
sedimentation and centrifugation over Ficoll cushions. Neutrophils
were resuspended at a concentration of 1 106/ml in PBS buffer in
the presence and absence of an LTB4 receptor antagonist (LY 223982
10 M; Eli Lilly, Basingstoke, UK), or 15(S)-HETE (1–100 M), at
37°C. Chemotaxis was performed using a 48-well microchemotaxis
chamber (Costar; Neuro Probe Inc., Cabin John, MD) as previously
described (Profita et al., 2000a). Neutrophils were loaded into the
upper well and the monocyte supernatant, or synthetic compound,
were placed in the bottom chamber. The two wells were separated by
a polycarbonate membrane filter with a pore size of 3 m. Chamber
was incubated at 37°C for 1 h. At the end of incubation, the filter was
fixed, stained, and mounted on a glass microscope slide (observed at
400). Migration was assessed by counting the number of cells that
had migrated beyond a certain depth into the filter. Each experimen-
tal condition was performed in duplicate, and three to four fields
were assessed for cell migration. Chemotactic activity of standard
15(S)-HETE, 5(S),15(S)-diHETE, and LTB4 dissolved in PBS buffer
was also evaluated.
Uptake and Metabolism of Radiolabeled 15(S)-HETE. Me-
tabolism of 15(S)-HETE by monocytes (2  106 cells), was studied in
cells grown for 72 h with and without IL-4 (10 ng/ml). Cells were then
incubated with [3H]15(S)-HETE (0.5 Ci/ml) for 20 min at 37°C, and
stimulated with A23187 at a final concentration of 5  106 M for 15
min 37°C, in the presence or absence of MK-886. At the end of the
incubation the cell-free medium was analyzed by RP-HPLC as de-
scribed above. One-minute fractions were collected and radioactivity
analyzed by liquid scintillation counting.
Statistical Analysis. Results are given as mean  S.E. of n
observations. Statistical analysis was performed by one-way analysis
of variance. Mean data for individual experiments were also com-
pared using Student’s t test for paired or unpaired samples, as
appropriate. A p value  0.05 was considered statistically signifi-
cant.
Results
Treatment with IL-4 for 24, 48, and 72 h significantly
increased the amount of 15(S)-HETE observed after stimu-
lation with the Ca2 ionophore A23187, resulting in over a
10-fold increase after 72 h of incubation (Fig. 1A). Concomi-
tant measurement of LTB4 production showed a progressive
decrease over IL-4 incubation time, reaching a minimum
after 72 h, where LTB4 production was less than 15% of that
observed in the absence of IL-4 pretreatment (Fig. 1B). The
effect of IL-4 was abolished upon pretreatment with a specific
anti-IL-4 polyclonal antibody, and the production of 15(S)-
HETE and LTB4 after 72 h of incubation with IL-4 resulted
in 2.1  1 and 3.5  1.1 ng/ml, respectively, compared with
values of 22.6  2.5 and 0.6  0.1 ng/ml observed in samples
treated with IL-4 in the absence of the anti-IL-4 polyclonal
antibody.
To test if the effect of IL-4 on LTB4 could be observed in the
presence of a more physiological stimulus, control and IL-4-
treated (72 h) monocytes were challenged with opsonized
zymosan. LC/MS/MS analysis of supernatants showed the
presence of 15(S)-HETE in IL-4-treated cells only (Fig. 2). As
observed in A23187-activated monocytes, LTB4 production in
IL-4-treated monocytes was also inhibited (45  11%, n  3,
p 0.05; LTB4 production in controls was 0.44 0.24 ng/2
106 cells).
In agreement with data previously published, 15-LO activity,
evaluated upon addition of excess arachidonic acid (Table 1), as
well as 15-LO mRNA (Fig. 3) showed a significant increase in
IL-4 treated monocytes compared with untreated cells. On the
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contrary, the decrease in LTB4 production observed in IL-4
treated monocytes did not reflect decreased expression of
mRNA for enzymes involved in its synthesis, such as 5-LO and
FLAP (Fig. 3).
To verify if newly expressed 15-LO, which utilizes AA, may
reduce LTB4 biosynthesis simply by decreasing substrate
availability, monocytes were challenged in the presence of
excess substrate (30 M AA). The results showed a signifi-
cant decrease of LTB4 in IL-4-treated monocytes compared
with untreated cells (10  3 and 98  3 ng/ml, respectively;
n  3, p  0.01).
We have previously shown that 15(S)-HETE is able to
inhibit the synthesis of 5-LO metabolites in human neutro-
phils. To test if the product of arachidonic acid metabolism by
15-LO may be responsible for the observed inhibition of LTB4
production, we tested the effect of 15(S)-HETE on A23187-
induced formation of LTB4. Preincubation of isolated mono-
cytes with exogenous 15(S)-HETE prior to A23187 challenge
resulted in a concentration-dependent inhibition of LTB4
production, with an IC50 of 1 M (Fig. 4). The observed
inhibitory effect did not reflect a decreased availability of the
substrate, as AA release was not reduced by pretreatment
with 15(S)-HETE (31.5  7.5 and 50.6  11.5 ng/2  106
cells; control and 15(S)-HETE 105 M, respectively).
Incubation of radiolabeled 15(S)-HETE with human mono-
cytes showed significant production of the double lipoxygen-
ation product 5(S),15(S)-diHETE when cells were activated
with A23187 (Fig. 5). Formation of 5(S),15(S)-diHETE re-
quired 5-LO activation and translocation as shown by com-
plete inhibition of its synthesis by the FLAP inhibitor MK-
886. LC/MS/MS analysis of monocytes preincubated with
15(S)-HETE, also showed the presence of the 5(S),15(S)-
diHETE, as detected by the specific transition from m/z 335
to 201 (data not shown).
Given the potent neutrophil chemotactic activity of LTB4,
it was of interest to see if the treatment with IL-4 was able to
significantly affect the biological activity of the substances
Fig. 1. Effects of IL-4 on 15(S)-HETE and LTB4 production in human
monocytes. The effects of IL-4 treatment on the production of 15(S)-
HETE (A) and LTB4 (B) were evaluated in normal human peripheral
monocytes activated with A23187 (5 M). Monocytes (2  106 cells/ml)
were cultured in the presence or absence of IL-4 for 24, 48, and 72 h.
15(S)-HETE and LTB4 were quantified in supernatants by specific RIAs
after RP-HPLC separation as described under Materials and Methods.
Data are expressed as mean  S. E. of eight consecutive experiments.
Statistical analysis was performed using Student’s t test for unpaired
samples.
Fig. 2. LC/MS/MS analysis of supernatant from opsonized zymosan-
activated human monocytes. Untreated (top panel) and IL-4 treated
(bottom panel; 10 ng/ml, 72 h, 37°C) monocytes were challenged with
opsonized zymosan (100 particles per cell, 1 h at 37°C). Supernatant was
extracted and analyzed by LC/MS/MS as described under Materials and
Methods. Negative ion chromatograms represent the specific transition
from m/z 319 to m/z 219, resulting from the collision induced dissociation
of the carboxylate anion of 15(S)-HETE.
TABLE 1
15-LO enzymatic activity in IL-4-treated monocytes
Monocytes (2  106/ml) treated with and without IL-4 (10 ng/ml) for 24, 48, and 72 h
were incubated with AA (100 M) for 15 min. 15(S)-HETE was quantified in super-
natants by specific RIA after RP-HPLC separation as described under Materials and
Methods. Results are expressed as mean  S.E. of six consecutive experiments.
Statistical analysis was performed using Student’s t test for unpaired samples.
15-HETE (ng/ml)
Control AA (100 M)
Baseline 0.2  0.1 86  0.5
IL-4 (24 h) 0.2  0.1 134  7*
IL-4 (48 h) 1.5  0.2 566  45**
IL-4 (72 h) 0.4  0.2 745  132**
* p  0.05; ** p  0.01 vs. baseline.
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released by activated monocytes. We therefore evaluated the
neutrophil chemotactic activity of supernatants obtained
from control and IL-4-treated (72 h) monocytes after chal-
lenge with A23187. Neutrophil chemotaxis induced by the
supernatants of A23187-activated monocytes was signifi-
cantly lower in IL-4-treated monocytes (Fig. 6). To evaluate
the specific contribution of LTB4 to the overall chemotactic
activity released by activated monocytes, we also tested their
activity in the presence of the specific LTB4 receptor antag-
onist LY 223982. Pretreatment with LY 223982 significantly
inhibited the chemotactic activity of supernatants from con-
trol monocytes, pointing out that about 50% of the chemotac-
tic activity released by activated monocytes was the result of
the biological activity of LTB4. A similar pretreatment did
not have significant effects against the chemotactic activity
of supernatants obtained from IL-4 treated cells (Fig. 6),
suggesting that the reduced biological activity released by
IL-4-treated monocytes upon A23187 activation well corre-
lated with the decreased amounts of LTB4 observed under
these experimental conditions.
Given that significant neutrophil chemotactic activity has
previously been reported for 15(S)-HETE in vivo (Johnson et
al., 1985), we tested the in vitro chemotactic activity of 15(S)-
HETE and 5(S),15(S)-diHETE. Both compounds, at the con-
centration of 1 M, had an efficacy that was less than 50% of
the effect observed for LTB4 10 nM, tapering off at a higher
concentration (Fig. 7); the lower efficacy and potency for
15-LO metabolites as chemotactic factors is well in agree-
ment with the observed reduction of chemotactic activity
observed in supernatants from the IL-4-treated monocyte,
where a shift of arachidonic acid metabolism from LTB4 to
15(S)-HETE was observed.
Discussion
The results of this study showed that IL-4 induced expres-
sion of 15-LO in human monocytes is accompanied by a
significant inhibition of LTB4 production upon challenge
with either the Ca2 ionophore A23187 or a physiologically
relevant stimulus such as opsonized zymosan. Inhibition of
LTB4 synthesis upon treatment with IL-4 and activation of
monocytes in the presence of excess AA, showed that the
effect of IL-4 did not simply reflect the presence of newly
expressed 15-LO, and therefore a potential decrease in sub-
strate availability to 5-LO.
Treatment with IL-4 did not change the expression of
mRNA for key enzymes involved in leukotriene biosynthesis,
such as 5-LO and FLAP. Although we did not measure actual
proteins or enzymatic activity, the results of the mRNAs
expression suggest that the observed inhibition of LTB4 syn-
thesis did not result from a direct transcriptional effect of
IL-4 on 5-LO and FLAP. Concerning the potential effect of
IL-4 on the LTA4 hydrolase, a recent paper reported that IL-4
may indeed increase the expression of this enzyme (Zaitsu et
al., 2000). Exogenous 15(S)-HETE concentration-depen-
dently inhibited the formation of LTB4 by monocytes, with-
out affecting the availability of the substrate AA, as evalu-
ated measuring the AA released after A23187 challenge; this
result suggests that 15(S)-HETE formed by IL-4-treated
monocytes may be responsible for the observed inhibition of
LTB4 production.
IL-4 is a cytokine released by Th2 and mast cells (Bradding
et al., 1995) that may play a major role in the pathogenesis of
inflammatory lung disease (Robinson et al., 1992; Walker et
al., 1992; Humbert et al., 1996). Besides its IgE-regulating
effects (Del Prete et al., 1988; Pene et al., 1988), IL-4 is
involved in the maturation of blood monocytes (Mosmann et
al., 1986), as well as in the expression of cell membrane
markers such as CD23 and class II major histocompatibility
complex antigen on monocytes (de Velde et al., 1988). On the
other hand, together with its potential proinflammatory ac-
tivity, in normal subjects IL-4 has been found to be an inhib-
itor of mononuclear phagocyte functions in vitro and ex vivo
(Hart et al., 1989; Yanagawa et al., 1991; Wong et al., 1992).
Fig. 3. Expression of lipoxygenases and FLAP mRNA in normal human
peripheral monocytes cultured in the presence and absence of IL-4 for
72 h. Equal amounts of total RNA (2 ng) obtained from monocytes were
reverse-transcribed into cDNA. 5-LO and FLAP were amplified with
nested specific primers. Arrows indicate predicted sizes (bp) of amplifi-
cation products. Number on the top of figure indicates the sample: lane 1,
size marker (pBR322 DNA-Mps I Digest Biolabs, Beverly, MA); lane 2,
monocytes without IL-4; lane 3, monocytes with IL-4 (10 ng/ml) for 72 h;
lane 4, negative control (no template cDNA control).
Fig. 4. Effect of exogenous 15(S)-HETE on LTB4 production by human
monocytes challenged with A23187. Monocytes (2  106 cells/ml) were
preincubated with increasing concentrations of 15(S)-HETE and chal-
lenged with A23187 (5 M) for 15 min. LTB4 was quantified in superna-
tants by specific RIA after RP-HPLC separation as described under
Materials and Methods. Results are expressed as mean  S.E. of six
consecutive experiments. Statistical analysis was performed using Stu-
dent’s t test for paired samples.
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This inhibition appeared to be mediated by transcriptional
effects of IL-4 (Yanagawa et al., 1991) and was not due to a
cytotoxic effect.
The potential for IL-4 to significantly change the profile of
arachidonic acid metabolites from the production of leukotri-
enes to that of 15(S)-HETE raises important questions on the
biological relevance of such an effect. 15(S)-HETE represents
the major AA metabolite produced in lung homogenates
(Hamberg et al., 1980), as well as in cultured human lung
tissue obtained from both asthmatic and normal donors. It
has been shown that when lung tissue obtained from asth-
matics undergoes in vitro allergen challenge, 15(S)-HETE
production is approximately 100 times greater than that of
LTC4 (Dahlen, 1983). Bronchial allergen challenge in atopic
asthmatic subjects leads to a 30-fold increase of the concen-
trations of 15(S)-HETE recovered in bronchoalveolar lavage
fluid (Murray et al., 1986). Once released, 15(S)-HETE can
exert several immunoregulatory functions that may be rele-
vant to the pathogenesis of asthma. 15(S)-HETE has been
shown to be a potent mucosecretagogue in the human airway
(Marom et al., 1982), and to possess chemotactic activity for
neutrophils directly, contributing to the recruitment of these
cells in the airways (Johnson et al., 1985). It has also been
found that 15(S)-HETE can prolong the duration of airway
obstruction during the early response, suggesting that it
either augments the release of mediators from mast cells or
potentiates the effects of other mediators on airway smooth
muscle (Lai et al., 1990). On the other hand, it has been
reported that 15(S)-HETE inhibits 5-lipoxygenase (Vander-
hoek et al., 1980; Borgeat et al., 1983; Profita et al., 2000a),
and incorporation of 15(S)-HETE into membrane phospho-
lipids impairs the response of human polymorphonuclear
neutrophil to inflammatory stimuli such as the formylated
tripeptide fMLP (Brezinski and Serhan, 1990).
Recently we showed that 15(S)-HETE is present in high
concentration in induced sputum obtained from asthmatics
(Profita et al., 2000b), as well as that of chronic bronchitis
patients (Profita et al., 2000a). Furthermore we showed that
its concentration inversely correlates with the percentage of
neutrophils recovered in induced sputum, and that 15(S)-
HETE inhibits LTB4 production in A23187, as well as in
fMLP-activated human neutrophils (Profita et al., 2000a).
Hence, the ability of IL-4 to increase the release of 15(S)-
HETE by human monocytes/macrophages, and to concomi-
tantly inhibit the production of a potent chemotactic factor
such as LTB4, may play an important role in the evolution of
pulmonary inflammatory responses. In agreement with the
expected effect of reduced production of LTB4, supernatants
from IL-4-treated monocytes showed a significantly lower
chemotactic activity toward neutrophils. Neutrophil chemo-
taxis evaluation in the presence of an LTB4-receptor antag-
onist showed that over 50% of the chemotactic activity of
activated monocytes depends on the presence of the 5-LO
metabolite LTB4. This result suggests that neutrophilic in-
flux following monocyte activation may be significantly in-
hibited by the expression of 15-LO induced by IL-4.
A recent paper raised the possibility that inhibition of 5-LO
product formation by 15(S)-HETE in human neutrophils
Fig. 5. Metabolism of radiolabeled
15(S)-HETE by human monocytes.
Monocytes (2  106 cells/ml) were pre-
incubated with radiolabeled 15(S)-
HETE and challenged with A23187 (5
M) for 15 min in the presence or ab-
sence of the FLAP inhibitor compound
MK-886 (1 M). Supernatants were ex-
tracted and analyzed by RP-HPLC as
described under Materials and Meth-
ods. One-minute aliquots were col-
lected and radioactivity was evaluated
by liquid scintillation counting. Reten-
tion time of synthetic standard com-
pounds are shown by arrows.
Fig. 6. Effect of IL-4 treatment on neutrophil chemotactic activity of
supernatants from A23187-challenged monocytes. Chemotaxis was per-
formed using a 48-well microchemotaxis chamber as described under
Materials and Methods. Neutrophils were preincubated either in the
absence or the presence of the LTB4 receptor antagonist LY 223982 at the
concentration of 10 M. Results are expressed as mean  S.E. of eight
consecutive experiments. Statistical analysis was performed using Stu-
dent’s t test for unpaired samples.
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(Petrich et al., 1996) may simply reflect that 15(S)-HETE is
an alternative substrate to arachidonic acid for 5-LO. We
tested the metabolism of radiolabeled 15(S)-HETE in mono-
cytes and found that measurable formation of the dihydroxy-
derivative 5(S),15(S)-diHETE could indeed be observed. In-
terestingly, as recently shown by Mancini and coworkers by
selective expression of 5-LO and FLAP in Sf9 insect cells
(Mancini et al., 1998), conversion of 15(S)-HETE by 5-LO was
dependent on FLAP, and pretreatment with the FLAP inhib-
itor MK-886 completely abolished the conversion of radiola-
beled 15(S)-HETE in monocytes. This evidence suggests that
FLAP is responsible for appropriate handling of substrate,
either AA of 15(S)-HETE, to 5-LO. Irrespective of the mech-
anism underlying the inhibition of LTB4 synthesis (true in-
hibitor or alternative substrate) it is important to stress that
IL-4-induced expression of 15-LO causes a significant shift in
arachidonic acid metabolism from LTB4 to 15(S)-HETE, and
possibly minor amounts of 5(S),15(S)-diHETE. This shift ap-
pears to be biologically relevant as we found that 15(S)-
HETE, as well as 5(S),15(S)-diHETE, both showed only a
very modest neutrophil chemotactic activity (approximately
50% of the efficacy of LTB4 at 100-fold higher concentration);
furthermore this effect tapered off at higher concentrations.
This modest chemotactic activity may be responsible for the
results observed after in vivo administration of 15-HETE in
dogs, in which enhanced influx of neutrophils as well as mast
cells was observed (Johnson et al., 1985). On the other hand,
the potential effect on the production of LTB4 may contribute
to the observed inhibitory effect of 15(S)-HETE on neutrophil
responses in vitro (Brezinski and Serhan, 1990). These com-
plex mechanisms may well play a role in the regulation of the
resolution of the inflammatory response.
In conclusion, this study shows that in human monocytes
IL-4 may directly regulate the production of arachidonic acid-
derived lipid mediators, such as LTB4 and 15(S)-HETE,
therefore contributing to the evolution of inflammatory re-
sponses resulting in monocyte activation. The evidence pro-
vided in this study underscores a potential modulatory role
for IL-4 in the inflammatory response, unveiling a novel
anti-inflammatory activity of this cytokine.
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